CDIN1

CDIN1 (C15orf41) is a nuclear, nucleolus-enriched protein that functions as an obligate partner of Codanin-1 (CDAN1) in a pathway required for erythroid differentiation, and biallelic mutation of CDIN1 causes congenital dyserythropoietic anemia type I (CDA-I) (PMID:23716552, PMID:31191338). Sequence and structural analysis place CDIN1 in the Holliday junction resolvase family of restriction endonucleases (PMID:23716552). CDIN1 forms a high-affinity, near-stoichiometric heterodimer with the C-terminal region of Codanin-1; this interaction stabilizes CDIN1 protein levels and governs its localization, with Codanin-1 sequestering CDIN1 within larger cytosolic complexes (PMID:32239177, PMID:41609415). These complexes also contain dimeric CDAN1 and multiple copies of the histone H3-H4 chaperones ASF1A/B, which CDAN1 engages and inhibits by mimicking histone H3 and occupying all ASF1 binding sites, placing the CDIN1-Codanin-1 module within histone chaperone regulation (PMID:40091041). In patient-derived erythroid cells, CDAN1 and CDIN1 are enriched in nucleoli that are structurally abnormal, and loss of function delays terminal erythroid differentiation, increases proliferation, and broadly alters chromatin accessibility (PMID:33121234). CDA-I-associated mutations in either CDIN1 or Codanin-1 disrupt the CDIN1-Codanin-1 interaction, defining loss of this complex as the shared molecular basis of the disease (PMID:41609415). The catalytic activity predicted for CDIN1 has not been demonstrated enzymatically in the available corpus.

1. 2013 Low

   Established CDIN1 as a disease gene and assigned a predicted molecular identity, framing the question of what biochemical function underlies CDA-I.

   Evidence Whole genome sequencing with segregation analysis and sequence/structural bioinformatics identifying homozygous missense mutations

   PMID:23716552

   Open questions at the time

   • Endonuclease/resolvase activity is purely computational with no in vitro enzymatic demonstration
   • No substrate identified
   • No mechanistic link between predicted nuclease function and erythropoiesis
2. 2019 Medium

   Showed where CDIN1 acts and that disease mutations are functionally consequential, linking the protein to erythroid differentiation and cell cycle control.

   Evidence Immunofluorescence localization, western blot of mutant protein levels, and erythroid differentiation and cell cycle assays in K562 cells

   PMID:31191338

   Open questions at the time

   • Mechanism connecting mutations to differentiation defect unresolved
   • Single cell-line model
   • No direct biochemical activity tested
3. 2020 High

   Defined CDIN1's primary physical partner, revealing that CDIN1 is a Codanin-1-dependent protein whose stability and localization are controlled by complex formation.

   Evidence Reciprocal co-immunoprecipitation, in vitro characterization, overexpression-driven localization shifts, immunofluorescence, and phylogenetic co-loss profiling across multiple independent labs

   PMID:32239177 PMID:32293259 PMID:32518175

   Open questions at the time

   • Functional consequence of nucleolar enrichment not defined
   • Whether CDIN1 has activity independent of Codanin-1 unknown
   • Interface residues not yet mapped at this stage
4. 2021 Medium

   Connected the CDIN1-Codanin-1 complex to a cellular phenotype, showing nucleolar abnormalities and chromatin disorganization in patient erythroid cells and a common mechanism for CDAN1 and CDIN1 mutations.

   Evidence Patient-derived erythroid cultures, electron microscopy, immunofluorescence, ATAC-seq, flow cytometry, and Cdan1 mouse knockout

   PMID:33121234 PMID:35441598

   Open questions at the time

   • Causal chain from complex loss to altered chromatin accessibility not established
   • CDIN1-specific knockout phenotype not separated from CDAN1
   • Direct role of CDIN1 in chromatin organization untested
5. 2025 High

   Provided the structural context placing CDIN1 within a CDAN1-ASF1 cytosolic assembly that inhibits histone chaperone function by histone H3 mimicry.

   Evidence Single-particle cryo-EM with biochemical reconstitution, pulldowns, and mutagenesis (peer-reviewed; superseding the 2024 bioRxiv preprint)

   PMID:39149339 PMID:40091041

   Open questions at the time

   • CDIN1's structural placement and role within the assembly not resolved at atomic level
   • Whether CDIN1 contributes to ASF1 inhibition unknown
   • No catalytic function assigned to CDIN1 in the complex
6. 2026 High

   Quantified the CDIN1-Codanin-1 interaction and demonstrated that CDA-I mutations on either protein disrupt it, pinning the disease mechanism to loss of the heterodimer.

   Evidence Complementary biophysical affinity and stoichiometry measurements, structural analysis, and disease-mutant functional validation

   PMID:41609415

   Open questions at the time

   • Downstream molecular event triggered by complex disruption unknown
   • Single lab
   • Does not establish enzymatic role of CDIN1

• The predicted endonuclease/resolvase catalytic activity of CDIN1 and its physiological substrate remain undemonstrated, leaving the link between its molecular activity and erythroid chromatin biology unresolved.
• No in vitro nuclease activity shown
• No DNA or RNA substrate identified
• Mechanistic role of CDIN1 within the CDAN1-ASF1 complex undefined